A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine

PHASE2RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 30, 2024

Primary Completion Date

December 30, 2030

Study Completion Date

December 30, 2030

Conditions
Solid Tumours
Interventions
DRUG

Brigimadlin

Brigimadlin

Trial Locations (50)

1200

RECRUITING

Cliniques Universitaires Saint-Luc, Brussels

2031

RECRUITING

Prince of Wales Hospital-Randwick-66496, Randwick

2100

RECRUITING

Copenhagen University Hospital, Rigshospitalet, København Ø

3000

RECRUITING

UZ Leuven, Leuven

3200

ACTIVE_NOT_RECRUITING

Clinexpert Gyongyos, Gyöngyös

4102

RECRUITING

Princess Alexandra Hospital, Woolloongabba

11042

NOT_YET_RECRUITING

Northwell Health, Lake Success

11217

RECRUITING

Taipei Veterans General Hospital, Taipei

13125

ACTIVE_NOT_RECRUITING

Helios Klinikum Berlin-Buch, Berlin

15706

RECRUITING

Hospital Clínico de Santiago, Santiago de Compostela

20133

RECRUITING

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

28040

RECRUITING

Fundación Jiménez Díaz, Madrid

28041

COMPLETED

Hospital Universitario 12 de Octubre, Madrid

28050

RECRUITING

Hospital Universitario HM Sanchinarro, Madrid

32224

RECRUITING

Mayo Clinic Cancer Center, Jacksonville

35042

RECRUITING

CTR Eugène Marquis, Rennes

35128

RECRUITING

Istituto Oncologico Veneto IRCCS, Padua

37232

NOT_YET_RECRUITING

Henry-Joyce Cancer Clinic, Nashville

38138

RECRUITING

West Cancer Center & Research Institute, Germantown

50009

NOT_YET_RECRUITING

Hospital Miguel Servet, Aragon

53792

COMPLETED

University of Wisconsin, Madison

63108

RECRUITING

Washington University School of Medicine, St Louis

68130

RECRUITING

Nebraska Cancer Specialists-Omaha-69066, Omaha

69373

ACTIVE_NOT_RECRUITING

CTR Leon Berard, Lyon

72076

ACTIVE_NOT_RECRUITING

Universitätsklinikum Tübingen, Tübingen

77030

RECRUITING

The University of Texas MD Anderson Cancer Center, Houston

77900

NOT_YET_RECRUITING

University Hospital Olomouc, Olomouc

84106

COMPLETED

Utah Cancer Specialists Cancer Center, Salt Lake City

90212

RECRUITING

Precision NextGen Oncology, Beverly Hills

90403

RECRUITING

Sarcoma Oncology Center, Santa Monica

98109

RECRUITING

Fred Hutchinson Cancer Research Center, Seattle

510060

NOT_YET_RECRUITING

Sun Yat-Sen University Cancer Center, Guangzhou

6423906

COMPLETED

Sourasky Medical Center, Tel Aviv

06511

RECRUITING

Yale Cancer Center, New Haven

C1120AAB

RECRUITING

Sanatorio Finochietto, CABA

T2N 5G2

ACTIVE_NOT_RECRUITING

Arthur J. E. Child Comprehensive Cancer Centre, Calgary

M5G 2M9

ACTIVE_NOT_RECRUITING

Princess Margaret Cancer Centre, Toronto

811-1395

RECRUITING

National Hospital Organization Kyushu Cancer Center, Fukuoka, Fukuoka

812-8582

RECRUITING

Kyushu University Hospital, Fukuoka, Fukuoka

241-8515

RECRUITING

Kanagawa Cancer Center, Kanagawa, Yokohama

980-8574

RECRUITING

Tohoku University Hospital, Miyagi, Sendai

700-8558

RECRUITING

Okayama University Hospital, Okayama, Okayama

541-8567

RECRUITING

Osaka International Cancer Institute, Osaka, Osaka

104-0045

RECRUITING

National Cancer Center Hospital, Tokyo, Chuo-ku

N-0379

COMPLETED

Oslo Universitetssykehus HF, Radiumhospitalet, Oslo

02-781

NOT_YET_RECRUITING

Oncology Center-Maria Sklodowska-Curie Institute, Warsaw

SE-171 76

RECRUITING

Karolinska Comprehensive Cancer Center, Stockholm

CB2 0QQ

RECRUITING

Addenbrooke's Hospital, Cambridge

NW12PQ

RECRUITING

University College Hospital, London

SW3 6JJ

RECRUITING

The Royal Marsden Hospital, Chelsea, London

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06619509 - A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine | Biotech Hunter | Biotech Hunter